Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the national cancer institute breast and prostate cancer cohort consortium
Konstantinos K. Tsilidis, Ruth C. Travis, Paul N. Appleby, Naomi E. Allen, Sara Lindstrom, Fredrick R. Schumacher, David Cox, Ann W. Hsing, Jing Ma, Gianluca Severi, Demetrius Albanes, Jarmo Virtamo, Heiner Boeing, H. Bas Bueno-De-Mesquita, Mattias Johansson, J. Ramón Quirós, Elio Riboli, Afshan Siddiq, Anne Tjønneland, Dimitrios TrichopoulosRosario Tumino, J. Michael Gaziano, Edward Giovannucci, David J. Hunter, Peter Kraft, Meir J. Stampfer, Graham G. Giles, Gerald L. Andriole, Sonja I. Berndt, Stephen J. Chanock, Richard B. Hayes, Timothy J. Key
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the national cancer institute breast and prostate cancer cohort consortium'. Together they form a unique fingerprint.